NEW YORK, Aug. 24 /PRNewswire/ -- The DNA sequencing equipment market is expected to grow nearly 8% between 2006 and 2012, spiraling upward from $335 million to $528 million as competition intensifies and diversifies, according to DNA Sequencing Equipment and Service Markets, a new report by Kalorama Information.
The DNA sequencer market has been relatively stable for the last several years, with one dominant vendor and relatively few changes taking place in the products or technologies. However, the completion of several new products by 454 Life Sciences, Illumina/Solexa, and Applied Biosystems and the availability of vast amounts of annotated sequence data have allowed researchers to undertake a much wider range of experiments, fragmenting the market and moving products into additional segments with their own needs.
The emergence of several next-generation products with new applications, including gene expression analysis and epigenetics, in the next few years will also make a huge impact on the market. Growth is expected to be stimulated by the introduction of these new technologies and by researchers' essentially endless numbers of samples to analyze.
Although the new technologies will analyze much larger numbers of samples, researchers' demand will need to catch up to the increased capacity provided by the new purchases over the next couple of years, which will result in slower growth after the initial burst.
"The next two to three years will be a volatile time in the market, while the winners and losers get shaken out," said Justin Saeks, author of DNA Sequencing Equipment and Service Market. "Various aspects, including scientific, business, technology, and regulatory changes, could each turn out to play an unexpected role."
DNA Sequencing Equipment and Service Market covers DNA sequencing
products used by the academia, government, pharmaceutical, and
biotechnology industries. The report analyzes products in development and
|SOURCE Kalorama Information|
Copyright©2007 PR Newswire.
All rights reserved